A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
